Trial Profile
Human Amniotic Epithelial Stem Cell in Treatment of Refractory Severe Intrauterine Adhesion
Status:
Not yet recruiting
Phase of Trial:
Phase 0
Latest Information Update: 10 Sep 2023
Price :
$35
*
At a glance
- Drugs Human amniotic epithelial cells-Shanghai-iCELL-Biotechnology (Primary)
- Indications Genitourinary disorders
- Focus Therapeutic Use
- 25 Oct 2020 Planned End Date changed from 1 Mar 2021 to 1 Sep 2023.
- 25 Oct 2020 Planned primary completion date changed from 1 Mar 2020 to 1 Sep 2022.
- 02 Jan 2018 New trial record